2022 Emerging Medical Technologies Spotlight Tool: Updated Monthly with 1,855 Companies - ResearchAndMarkets.com

29 Nov 2022
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Emerging Medical Technologies Spotlight" newsletter has been added to ResearchAndMarkets.com's offering.
Emerging Medical Technologies (EMT) Spotlight is a resource for strategic marketing, market research, business development, and investment executives seeking discreet and detailed business, market, and competitive intelligence on privately-held companies developing disruptive technologies in 24 markets.
This tool currently includes 1855 companies and is updated monthly.
LSI leverages multiple data streams to feed this robust resource, including:
Private Biotech, Device, and Pharma Companies at Various Stages of Development
Company Overviews and/or Executive Summaries from leading industry investment and partnering conferences
New companies added regularly outside of the conference circuit via the ongoing efforts of our In-House Research Team
The Complete EMT Spotlight Library provides access to all existing companies, new companies added monthly, and company updates through 2012 in all 24 markets.
Coverage includes emerging innovations in a broad spectrum of medical technology areas including:
Aesthetics/Dermatology
Biomaterials
Dental
Diagnostics
Endocrine
Gynecology/Women's Health
Imaging
Neurology
Oncology
Ophthalmology
Orthopedics
Pharmaceutical
Respiratory
Spine
Surgery
Urology
Vascular
Wound
Company Overviews
Data includes:
Company Name
Technology Details
Target Markets
Contact Info.
Location
Website
Year Established
More
Executive Summaries
Data includes:
All Company Overview Data +
Development Status
Competitive Landscape & Differentiation
Financial Summary & Sales Forecasts
IP Position & Status
Financing Status
Management Team Bios
More
For more information about this newsletter visit https://www.researchandmarkets.com/r/whjnxv
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.